AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$595M |
| 2 |
Verisk Analytics
VRSK
|
+$499M |
| 3 |
Otis Worldwide
OTIS
|
+$484M |
| 4 |
lululemon athletica
LULU
|
+$408M |
| 5 |
Microsoft
MSFT
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$384M |
| 2 |
Nike
NKE
|
+$341M |
| 3 |
Arista Networks
ANET
|
+$335M |
| 4 |
Visa
V
|
+$331M |
| 5 |
Cognizant
CTSH
|
+$308M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.66% |
| 2 | Healthcare | 18% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 10.25% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Stoke Therapeutics
STOK
$1.83B
| $163K | ﹤0.01% |
41,320
| – | – |
|
3002
908 Devices
MASS
$293M
| $162K | ﹤0.01% |
24,340
| – | – |
|
|
TPC
3003
Tutor Perini Cor
TPC
$4.51B
| $161K | ﹤0.01% |
20,595
| – | – |
|
3004
GrowGeneration
GRWG
$88.9M
| $161K | ﹤0.01% |
55,200
| – | – |
|
|
IAUX
3005
i-80 Gold Corp
IAUX
$1.16B
| $159K | ﹤0.01% |
103,820
+46,000
| +80% | +$90.2K |
|
3006
EyePoint Inc
EYPT
$1.04B
| $158K | ﹤0.01% |
19,820
+5,040
| +34% | +$55.3K |
|
3007
Seer Inc
SEER
$108M
| $158K | ﹤0.01% |
71,580
| – | – |
|
3008
BigBear.ai
BBAI
$1.36B
| $157K | ﹤0.01% |
103,850
-40,310
| -28% | -$70K |
|
|
TVRD
3009
Tvardi Therapeutics
TVRD
$23.8M
| $157K | ﹤0.01% |
2,589
| – | – |
|
3010
Summit Therapeutics
SMMT
$10.5B
| $156K | ﹤0.01% |
83,226
+10,686
| +15% | +$20.4K |
|
|
SGMO
3011
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $152K | ﹤0.01% |
254,021
| – | – |
|
|
KLRS
3012
Kalaris Therapeutics
KLRS
$85.2M
| $152K | ﹤0.01% |
3,073
+451
| +17% | +$30.7K |
|
3013
Mineralys Therapeutics
MLYS
$2.4B
| $151K | ﹤0.01% |
15,860
+4,780
| +43% | +$62.3K |
|
3014
SkyWater Technology
SKYT
$1.55B
| $151K | ﹤0.01% |
25,040
+2,800
| +13% | +$21.2K |
|
|
SEMR
3015
DELISTED
Semrush
SEMR
| $150K | ﹤0.01% |
17,690
+2,170
| +14% | +$20.2K |
|
3016
Xeris Biopharma Holdings
XERS
$1.42B
| $150K | ﹤0.01% |
80,420
+9,970
| +14% | +$22.8K |
|
3017
CarParts.com
PRTS
$39.7M
| $149K | ﹤0.01% |
3,620
| – | – |
|
3018
AirSculpt Technologies
AIRS
$331M
| $149K | ﹤0.01% |
21,760
+2,290
| +12% | +$18.3K |
|
|
API
3019
Agora
API
$337M
| $147K | ﹤0.01% |
58,295
+41,660
| +250% | +$119K |
|
3020
Quad
QUAD
$438M
| $140K | ﹤0.01% |
+27,920
| New | +$146K |
|
|
AEVA
3021
Aeva Technologies
AEVA
$1.06B
| $140K | ﹤0.01% |
36,572
-1,430
| -4% | -$7.56K |
|
3022
Olema Pharmaceuticals
OLMA
$1.05B
| $135K | ﹤0.01% |
+10,900
| New | +$111K |
|
|
CVAC
3023
DELISTED
CureVac
CVAC
| $134K | ﹤0.01% |
+19,691
| New | +$174K |
|
3024
Hyliion Holdings
HYLN
$681M
| $133K | ﹤0.01% |
112,710
-14,730
| -12% | -$22K |
|
3025
Humacyte
HUMA
$182M
| $133K | ﹤0.01% |
45,330
+8,000
| +21% | +$26.5K |
|
Similar funds
AllianceBernstein's Q3 2023 Portfolio in Review
As of Q3 2023, AllianceBernstein held 3,241 positions worth $235B, down 4.1% from $245B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.2%. AllianceBernstein opened 78 new positions and exited 57, leaving the 3,241-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2023 buy was CRH: 5,431,009 shares worth $297M.
- AllianceBernstein added most to Netflix in Q3 2023, an estimated $595M increase.
- AllianceBernstein's biggest Q3 2023 reduction was Apple, cutting an estimated $384M.
- AllianceBernstein fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $77.5M.
- AllianceBernstein's ten largest holdings make up 24% of its $235B portfolio in Q3 2023.
- AllianceBernstein opened 78 new positions and closed 57 in Q3 2023.
- AllianceBernstein's portfolio value fell 4.1% quarter-over-quarter to $235B.
Based on AllianceBernstein's 13F filing for Q3 2023, filed 14 Nov 2023.